Absent Mandatory Listing, US FDA Acknowledges Its Supplement Directory Isn’t Comprehensive
Two weeks after Commissioner Califf notes he supports mandatory listing of supplements and two months after previous session of Congress ended without imposing requirement, agency is doing what it can to publish information about ingredients in supplements sold in the country.
You may also be interested in...
The Dietary Supplement Market US FDA Is Regulating Isn’t Your 1994 DSHEA Version
“In the last 30 years, we've seen this sort of explosion, and it's not just more products and more sales. We're talking about more complex products,” says Cara Welch, FDA Office of Dietary Supplement Programs director. “Today's products are not the products from 1994.”
US FDA Food Safety Chief Looks Back On Full Plate Of Challenges, Funding Basket In Need Of More
“We don't have to look much further than our consumer complaint and adverse event systems to see that these upgrades are needed. Each year we receive nearly 10,000 consumer complaints and adverse event reports regarding FDA regulated foods and dietary supplements,” says Susan Mayne.
US Consumer Health Industry In 2023: Mandatory Listing Has Supplement Sector’s Attention
Chief executives of OTC drug and supplement industry trade groups discussed potential market and regulatory developments affecting their members’ businesses. HBW Insight reports here on whether support will emerge in Congress for FDA to gain MPL authority for all supplements sold in US.